Akkermansia muciniphila: study protocols
1 study group say how much Akkermansia muciniphila participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
98 products in our catalogue print how much Akkermansia muciniphila a serving holds.
Most common: 250 billion CFU to 500 billion CFU, 22% of 98 products.
| Dose per serving | Products |
|---|---|
| 0.05 billion CFU or less | 1 |
| 0.05 billion CFU to 0.1 billion CFU | 15 |
| 0.1 billion CFU to 0.25 billion CFU | 1 |
| 0.25 billion CFU to 0.5 billion CFU | 1 |
| 0.5 billion CFU to 1 billion CFU | 11 |
| 1 billion CFU to 2.5 billion CFU | 10 |
| 2.5 billion CFU to 5 billion CFU | 8 |
| 5 billion CFU to 10 billion CFU | 11 |
| 10 billion CFU to 25 billion CFU | 8 |
| 25 billion CFU to 50 billion CFU | 3 |
| 50 billion CFU to 100 billion CFU | 4 |
| 100 billion CFU to 250 billion CFU | 3 |
| 250 billion CFU to 500 billion CFU | 22 |
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
None of these 1 study group took Akkermansia muciniphila with anything else.
1 study group
| Study | |||
|---|---|---|---|
| Efficacy of ETB-F01, Heat-Killed Akkermansia muciniphila Strain EB-AMDK19, in Patients with Respiratory Symptoms: A Multicenter Clinical Trial 2024 · ETB-F01 group · Adults aged 19–70 with two or more respiratory symptoms (cough, sputum, or shortness of breath/chest tightness) lasting 4–12 weeks; asthma and COPD were excluded | 500 mg | 12 weeks | 77 |